BCL2 and non-small cell lung carcinoma: It is explained that in non-small-cell lung carcinoma (NSCLC), AEG-1 could impede apoptosis via elevating the anti-apoptotic protein BCL-2 level and also through activating PI3K/AKT pathway [46].